{"nctId":"NCT01320722","briefTitle":"Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function","startDateStruct":{"date":"2011-03"},"conditions":["Renal Function","Endothelial Function","Blood Pressure","Overweight","Obesity"],"count":242,"armGroups":[{"label":"Vitamin D","type":"EXPERIMENTAL","interventionNames":["Drug: Vitamin D ergocalciferol"]},{"label":"Probenecid","type":"EXPERIMENTAL","interventionNames":["Drug: Probenecid"]},{"label":"Allopurinol","type":"EXPERIMENTAL","interventionNames":["Drug: Allopurinol"]},{"label":"Placebo- Vitamin D","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]},{"label":"Placebo- Uric Acid","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Vitamin D ergocalciferol","otherNames":["Vitamin D"]},{"name":"Probenecid","otherNames":[]},{"name":"Allopurinol","otherNames":[]},{"name":"Placebo","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* 25(OH)D \\< 20 ng/mL OR Uric acid ≥ 5 mg/dL\n* Age ≥ 18, ≤ 75 years\n* Body Mass Index (BMI) ≥ 25 kg/m\\^2\n\nExclusion Criteria:\n\n* Hypertension, or on BP-lowering medicine\n* Diabetes\n* Coronary Heart Disease\n* estimated glomerular filtration rate (EGFR) \\<60 mL/min\n* Kidney stones\n* Active cancer (except non-melanoma skin cancer)\n* Pregnant\n* Taking vitamin D supplements and unwilling to stop\n* Osteoporosis\n* Hypo- or hypercalcemia\n* Hypo- or hyperphosphatemia\n* Known allergy to angiotensin-converting enzyme (ACE)-inhibitors\n* Taking medication for hyperuricemia\n* Gout, anemia, cirrhosis, active/chronic hepatitis, abnormal aspartate aminotransferase (AST), alanine aminotransferase (ALT) or total bilirubin levels, or anemia\n* Known allergy to either allopurinol or probenecid\n* Current use of didanosine, azothioprine, methotrexate, ketoprofen, ketorolac, mycophenolate, or ACE-inhibitors","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Renal Plasma Flow (RPF) in Response to Captopril in High Sodium Balance [Vitamin D]","description":"Change in RPF in response to captopril is a measure of the vasodilator effect from inhibiting angiotensin II (AngII)- mediated vascular tone and therefore the degree of kidney specific Renin Angiotensin System (RAS) activity. Participants consumed a high sodium diet 3 days prior to the test. Following an 8 hour fast, participants remained in a supine (lying down) position and had an intravenous (IV) catheter inserted in each arm, one for infusion and one for blood collection. An 8 milligrams (mg)/kilogram(kg) loading dose of para-aminohippuric acid (PAH) was given, immediately followed by a continuous PAH infusion at 12 mg/minute. After 60 minutes a single dose of 25 mg of captopril was administered. Three pre-captopril measurements and three post-captopril measurements of RPF were made. RPF was normalized to body surface area of 1.73 meters squared (m\\^2). The change in RPF was calculated as post-captopril RPF- pre-captopril RPF.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"35.7","spread":"47.7"},{"groupId":"OG001","value":"35.9","spread":"26.2"}]}]}]},{"type":"PRIMARY","title":"Plasma Renin Activity (PRA) [Vitamin D]","description":"PRA is a measure of systemic renin angiotensin system (RAS) activation. Blood was collected and plasma PRA was analyzed using a competitive binding radioimmunoassay (RIA) laboratory test.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.36","spread":"0.44"},{"groupId":"OG001","value":"0.44","spread":"0.8"}]}]}]},{"type":"PRIMARY","title":"Angiotensin II (ATII) Concentration [Vitamin D]","description":"ATII concentration is a measure of systemic renin angiotensin system (RAS) activation. Blood was collected and plasma ATII was analyzed using a double-antibody radioimmunoassay (RIA) laboratory test.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19.5","spread":"4.4"},{"groupId":"OG001","value":"19.7","spread":"7.1"}]}]}]},{"type":"PRIMARY","title":"Change in Renal Plasma Flow (RPF) Response to Captopril in High Sodium Balance [Uric Acid]","description":"RPF in response to captopril iis a measure of the vasodilator effect from inhibiting angiotensin II (AngII)- mediated vascular tone and therefore the degree of kidney specific Renin Angiotensin System (RAS) activity. Participants consumed a high sodium diet 3 days prior to the test. Following an 8 hour fast, participants remained in a supine (lying down) position and had an intravenous (IV) catheter inserted in each arm, one for infusion and one for blood collection. An 8 milligrams (mg)/kilogram(kg) loading dose of para-aminohippuric acid (PAH) was given, immediately followed by a continuous PAH infusion at 12 mg/minute. After 60 minutes a single dose of 25 mg of captopril was administered. Three pre-captopril measurements and three post-captopril measurements of RPF were made. RPF was normalized to body surface area of 1.73 meters squared (m\\^2). The change in RPF was calculated as post-captopril RPF- pre-captopril RPF.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"33","spread":null},{"groupId":"OG001","value":"36","spread":null},{"groupId":"OG002","value":"30","spread":null}]}]}]},{"type":"PRIMARY","title":"Plasma Renin Activity (PRA) [Uric Acid]","description":"PRA is a measure of systemic renin angiotensin system (RAS) activation. Blood was collected and plasma PRA was analyzed using a competitive binding radioimmunoassay (RIA) laboratory test.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":null},{"groupId":"OG001","value":"0.3","spread":null},{"groupId":"OG002","value":"0.2","spread":null}]}]}]},{"type":"PRIMARY","title":"Angiotensin II (ATII) Concentration [Uric Acid]","description":"ATII concentration is a measure of systemic renin angiotensin system (RAS) activation. Blood was collected and plasma ATII was analyzed using a double-antibody radioimmunoassay (RIA) laboratory test.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"20.3","spread":null},{"groupId":"OG001","value":"21.4","spread":null},{"groupId":"OG002","value":"19.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Endothelium-Dependent Vasodilation (EDV)","description":"Endothelial function was assessed by EDV using brachial artery ultrasonography. Measurements of brachial artery diameter were made under basal conditions and reactive hyperemia following ischaemic stimulus. A blood pressure cuff on the forearm was pumped up for 5 minutes then released. Images were taken at baseline and after reactive hyperemia (increased blood flow). The maximum diameter was determined by the investigator. Change in EDV was expressed as a percent of brachial luminal diameter calculated as post-ischaemic brachial artery diameter - pre-ischaemic brachial artery diameter/pre-ischaemic brachial artery diameter \\* 100.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.3","spread":"3.6"},{"groupId":"OG001","value":"7.9","spread":"4.7"},{"groupId":"OG002","value":"7.4","spread":"5.1"},{"groupId":"OG003","value":"7.6","spread":"6.0"},{"groupId":"OG004","value":"6.5","spread":"3.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.1","spread":"4.6"},{"groupId":"OG001","value":"6.8","spread":"4.7"},{"groupId":"OG002","value":"8.3","spread":"5.1"},{"groupId":"OG003","value":"6.2","spread":"4.8"},{"groupId":"OG004","value":"7.1","spread":"4.9"}]}]}]},{"type":"SECONDARY","title":"Mean 24-Hour Ambulatory Blood Pressure (ABP)","description":"A 24-hour mean ambulatory blood pressure was monitored using a 24 hour ABP device. The ABP device is a small box that is worn on the belt or pant/skirt line with a line that connect under the clothing to the cuff on the upper arm. Blood Pressure was recorded every 30 minutes during the day and every 60 minutes during the night for 24 hours.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"120.4","spread":"10.2"},{"groupId":"OG001","value":"123.7","spread":"7.6"},{"groupId":"OG002","value":"126.9","spread":"10.2"},{"groupId":"OG003","value":"124.1","spread":"8.8"},{"groupId":"OG004","value":"122.4","spread":"9.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.6","spread":"6.4"},{"groupId":"OG001","value":"73.7","spread":"5.8"},{"groupId":"OG002","value":"73.3","spread":"7.8"},{"groupId":"OG003","value":"72.1","spread":"7.1"},{"groupId":"OG004","value":"71.9","spread":"7.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"122.4","spread":"10.9"},{"groupId":"OG001","value":"126.4","spread":"7.4"},{"groupId":"OG002","value":"130.0","spread":"9.2"},{"groupId":"OG003","value":"126.7","spread":"8.4"},{"groupId":"OG004","value":"125.5","spread":"9.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"113.9","spread":"11.0"},{"groupId":"OG001","value":"116.5","spread":"8.7"},{"groupId":"OG002","value":"119.2","spread":"12.4"},{"groupId":"OG003","value":"117.1","spread":"10.0"},{"groupId":"OG004","value":"113.9","spread":"12.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"121.6","spread":"8.3"},{"groupId":"OG001","value":"124.7","spread":"9.6"},{"groupId":"OG002","value":"125.2","spread":"9.1"},{"groupId":"OG003","value":"123.7","spread":"9.4"},{"groupId":"OG004","value":"122.9","spread":"9.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.0","spread":"5.6"},{"groupId":"OG001","value":"74.7","spread":"7.2"},{"groupId":"OG002","value":"73.8","spread":"6.9"},{"groupId":"OG003","value":"72.0","spread":"6.5"},{"groupId":"OG004","value":"72.6","spread":"6.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"124.2","spread":"9.1"},{"groupId":"OG001","value":"127.6","spread":"9.2"},{"groupId":"OG002","value":"128.1","spread":"9.3"},{"groupId":"OG003","value":"125.1","spread":"9.6"},{"groupId":"OG004","value":"124.9","spread":"10.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"114.7","spread":"8.1"},{"groupId":"OG001","value":"117.4","spread":"11.4"},{"groupId":"OG002","value":"116.2","spread":"9.6"},{"groupId":"OG003","value":"118.6","spread":"11.7"},{"groupId":"OG004","value":"116.2","spread":"10.5"}]}]}]},{"type":"SECONDARY","title":"Mean 24-Hour Ambulatory Blood Pressure (ABP) Nocturnal Dipping","description":"A 24-hour mean ambulatory blood pressure was monitored using a 24 hour ABP device. The ABP device is a small box that is worn on the belt or pant/skirt line with a line that connect under the clothing to the cuff on the upper arm. Blood Pressure was recorded every 30 minutes during the day and every 60 minutes during the night for 24 hours. Nocturnal dipping is the percent change lower between the daytime and nighttime values.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.3","spread":"6.3"},{"groupId":"OG001","value":"7.8","spread":"5.1"},{"groupId":"OG002","value":"8.4","spread":"6.8"},{"groupId":"OG003","value":"7.5","spread":"5.3"},{"groupId":"OG004","value":"9.4","spread":"6.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.5","spread":"5.7"},{"groupId":"OG001","value":"8.1","spread":"6.0"},{"groupId":"OG002","value":"9.2","spread":"6.1"},{"groupId":"OG003","value":"5.2","spread":"7.1"},{"groupId":"OG004","value":"6.9","spread":"6.2"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":43},"commonTop":["Abdominal discomfort","Fatigue","Decreased appetite","Nausea","Headache"]}}}